U.S. Agency Seeks Reexamination Of Biotech Patent
In a sign of the government's increasing vigilance in protecting its patent rights, the U.S. Department of Health & Human Services has taken the highly unusual step of requesting an inter-partes...To view the full article, register now.
Already a subscriber? Click here to view full article